Skip to main content

The first U.S. trial for a coronavirus treatment has started

By Fortune  
   February 26, 2020

The National Institutes of Health (NIH) confirmed on Tuesday that the first U.S. clinical trial for a coronavirus treatment has launched at the University of Nebraska Medical Center (UNMC) in Omaha, Nebraska. The experimental therapy is biotech giant Gilead's remdesivir, an antiviral with the potential to treat a host of pathogens—including COVID-19, the disease caused by the new, novel coronavirus strain.

Full story

Get the latest on healthcare leadership in your inbox.